Extended Statement by the British Cardiovascular Intervention Society President Regarding Transcatheter Aortic Valve Implantation
Extended Statement by the British Cardiovascular Intervention Society President Regarding Transcatheter Aortic Valve Implantation
Transcatheter aortic valve implantation (TAVI) has now become the default intervention for severe, symptomatic aortic stenosis (AS) in inoperable and high-risk patients and patients at intermediate risk who are anatomically suitable for the transfemoral approach, under the guidance of a multidisciplinary heart team. Evidence is building for the use of TAVI in low-risk patients and as a result, the number of TAVI procedures in all developed nations is increasing dramatically. The number of TAVI procedures exceeded the number of isolated surgical aortic valve replacements in the US in 2015 and all surgical aortic valve replacements in 2018 according to the latest Transcatheter Valve Therapy Registry data.1 Although the UK is lagging behind most of these nations, the numbers of TAVI procedures is nevertheless increasing year by year. The British Cardiovascular Intervention Society (BCIS) has issued guidance as to how patients with AS should be managed and a service specification as to how TAVI should be performed.2 We hope this will go some way to standardising care across the UK for patients with AS but we are aware that much more needs to be done. BCIS is collaborating with the Valve for Life campaign to analyse inequities in TAVI provision in the UK and we hope to work with NHS commissioners to address this, and to encourage new centres to provide TAVI where local provision is inadequate or impossible with current facilities. The following document forms the basis of what will be a prolonged effort to improve TAVI provision in the UK and standardise its delivery.
e03
MacCarthy, Philip
d479e934-2d86-4942-9946-b48ac81b763d
Smith, Dave
c177294d-90d9-4283-b7e0-d7833135abf4
Muir, Douglas
ac518ef9-fb4a-43ce-b57d-fb52a929ebd7
Blackman, Daniel
1c03cb3f-3b7e-4f4c-94ed-9b438c4e6243
Buch, Mamta
0e4f2abf-28a3-41e9-a8ff-ec5d923f67eb
Ludman, Peter
28ef305d-e09e-40a7-84b4-6ccedfb37cc8
Appleby, Clare
bb8e2e92-71fa-4270-9382-f2923f02c2b1
Curzen, Nick
70f3ea49-51b1-418f-8e56-8210aef1abf4
Hildick-Smith, David
ed5133bd-17d3-48ad-8c2a-cfff6666bc7c
Uren, Neal
5d49a690-9157-4e91-825b-1bf44f4f866e
Turner, Mark
8949787b-4000-4407-8e6a-23a66540d7f2
Trivedi, Uday
b4e0ecd8-6836-4290-9a48-44454f7d4d3f
Banning, Adrian
c4929c3c-bbd4-4d99-8ff0-9b5526162070
April 2021
MacCarthy, Philip
d479e934-2d86-4942-9946-b48ac81b763d
Smith, Dave
c177294d-90d9-4283-b7e0-d7833135abf4
Muir, Douglas
ac518ef9-fb4a-43ce-b57d-fb52a929ebd7
Blackman, Daniel
1c03cb3f-3b7e-4f4c-94ed-9b438c4e6243
Buch, Mamta
0e4f2abf-28a3-41e9-a8ff-ec5d923f67eb
Ludman, Peter
28ef305d-e09e-40a7-84b4-6ccedfb37cc8
Appleby, Clare
bb8e2e92-71fa-4270-9382-f2923f02c2b1
Curzen, Nick
70f3ea49-51b1-418f-8e56-8210aef1abf4
Hildick-Smith, David
ed5133bd-17d3-48ad-8c2a-cfff6666bc7c
Uren, Neal
5d49a690-9157-4e91-825b-1bf44f4f866e
Turner, Mark
8949787b-4000-4407-8e6a-23a66540d7f2
Trivedi, Uday
b4e0ecd8-6836-4290-9a48-44454f7d4d3f
Banning, Adrian
c4929c3c-bbd4-4d99-8ff0-9b5526162070
MacCarthy, Philip, Smith, Dave, Muir, Douglas, Blackman, Daniel, Buch, Mamta, Ludman, Peter, Appleby, Clare, Curzen, Nick, Hildick-Smith, David, Uren, Neal, Turner, Mark, Trivedi, Uday and Banning, Adrian
(2021)
Extended Statement by the British Cardiovascular Intervention Society President Regarding Transcatheter Aortic Valve Implantation.
Interventional Cardiology, 16, .
(doi:10.15420/ICR.2021.02).
Abstract
Transcatheter aortic valve implantation (TAVI) has now become the default intervention for severe, symptomatic aortic stenosis (AS) in inoperable and high-risk patients and patients at intermediate risk who are anatomically suitable for the transfemoral approach, under the guidance of a multidisciplinary heart team. Evidence is building for the use of TAVI in low-risk patients and as a result, the number of TAVI procedures in all developed nations is increasing dramatically. The number of TAVI procedures exceeded the number of isolated surgical aortic valve replacements in the US in 2015 and all surgical aortic valve replacements in 2018 according to the latest Transcatheter Valve Therapy Registry data.1 Although the UK is lagging behind most of these nations, the numbers of TAVI procedures is nevertheless increasing year by year. The British Cardiovascular Intervention Society (BCIS) has issued guidance as to how patients with AS should be managed and a service specification as to how TAVI should be performed.2 We hope this will go some way to standardising care across the UK for patients with AS but we are aware that much more needs to be done. BCIS is collaborating with the Valve for Life campaign to analyse inequities in TAVI provision in the UK and we hope to work with NHS commissioners to address this, and to encourage new centres to provide TAVI where local provision is inadequate or impossible with current facilities. The following document forms the basis of what will be a prolonged effort to improve TAVI provision in the UK and standardise its delivery.
Text
ICR_MacCarthy_WEB
- Version of Record
More information
Published date: April 2021
Additional Information:
Publisher Copyright:
© RADCLIFFE CARDIOLOGY 2021.
Identifiers
Local EPrints ID: 451745
URI: http://eprints.soton.ac.uk/id/eprint/451745
ISSN: 1756-1485
PURE UUID: ca579274-dfe0-4a9d-9f1d-ac039829d573
Catalogue record
Date deposited: 25 Oct 2021 16:30
Last modified: 17 Mar 2024 03:02
Export record
Altmetrics
Contributors
Author:
Philip MacCarthy
Author:
Dave Smith
Author:
Douglas Muir
Author:
Daniel Blackman
Author:
Mamta Buch
Author:
Peter Ludman
Author:
Clare Appleby
Author:
David Hildick-Smith
Author:
Neal Uren
Author:
Mark Turner
Author:
Uday Trivedi
Author:
Adrian Banning
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
